Anti-LRRC32/TGFβ1 Antibody (Livmoniplimab)
Catalog No.
F2027
Anti-LRRC32/TGFβ1 Antibody (Livmoniplimab)
Featured Products
Livmoniplimab (ABBV-151) is an anti-GARP/TGF-β1 monoclonal antibody that blocks the release of active TGF-β1. Livmoniplimab has antitumor activity in mice with colon cancer. Livmoniplimab can be used in the study of locally advanced or metastatic solid tumors.
146.22 kDa
Dry ice
2412004-88-5
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
ABBV 151, AGRX-115, ABBV151
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q14392
Human
Unconjugated
Monoclonal
IgG4SP
ELISA, FACS, Kinetics, Functional assay, Animal Model
LRRC32 / TGFβ1
Please avoid freeze-thaw cycles.